Current Report Filing (8-k)
December 21 2018 - 5:48PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
________________________
FORM
8-K
________________________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 21, 2018
Earth
Science Tech Inc.
(Exact
name of Registrant as Specified in its Charter)
Nevada
|
|
000-55000
|
|
80-0961484
|
(State
or Other Jurisdiction
of Incorporation or Organization)
|
|
(Commission
file
number)
|
|
(I.R.S. Employer
Identification Number)
|
8000
NW 31st Street, Unit 19
Doral,
FL 33122, USA
(Address
of Principal Executive Offices including Zip Code)
(305)
615-2118
(Registrant’s
Telephone Number, including Area Code)
________________________________________________
Former
name or former address, if changed since last report
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
1.01 Entry into a Material Definitive Agreement
Effective
December 16, 2018, the Registrant entered into an agreement with Dermagate, Inc. to manufacture, assemble, and supply 5,000 units
of its MSN-2 medical device, Hygee™ , for purchase by Registrant, on an exclusive basis (“Hygee™”). The
parties have agreed to start manufacturing the 5,000 Hygee™ units in the weeks following execution of the agreement. The
pricing will be based upon the labor costs and a portion of Dermagates administrative costs in producing the units. In addition
Dermagate will receive a fraction of the profit made on each sale of Hygee based on the country where Hygee™ will be marketed.
The
agreement is preliminary in certain respects and fixed as to others, the parties have determined the initial number of units that
will be produced and the method of determining cost; however, the final numbers and percentage of profits as to specific countries
is still being determined as of the execution of the agreement.
The
Hygee™/MSN-2 Device
The
Hygee™ device itself, is a modified panty liner worn by women to allow for the self-collection of a gynecological specimen.
Currently the device allows human cells to be collected and tested for two types of infections, Chlamydia and Gonorrhea. It provides
women with the ability to be self-collect specimens in a non-clinical setting, send them to a laboratory that will process the
specimens and notify them if they test positive for either sexually transmitted disease so that they can seek treatment. This
technology allows the Company to provide diagnostic services to high-risk women and girls who are not inclined to visit traditional
medical settings. The kit can be ordered on-line for home screening.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Dated:
December 21, 2018
|
|
|
|
EARTH
SCIENCE TECH INC.
|
|
|
|
|
By:
|
/s/Nickolas
S. Tabraue
|
|
Name:
|
Nickolas
S. Tabraue
|
|
Title:
|
President
|
Earth Science Tech (PK) (USOTC:ETST)
Historical Stock Chart
From Aug 2024 to Sep 2024
Earth Science Tech (PK) (USOTC:ETST)
Historical Stock Chart
From Sep 2023 to Sep 2024